Holdco Nuvo Group DGNASDAQ: NUVO

Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart rate, and maternal uterine activity at home and in the clinic from the 32nd week of pregnancy until the beginning of labor. The company's INVU platform includes a wireless sensory band with multi-modality technology to capture signals to enable the INVU platform; and a cloud computing environment that processes and analyzes data and transmits personalized reports on maternal and fetal health metrics to the expectant mother and her obstetrician through digital visualization tools. It has a collaboration with Royal Philips and Charité – Universitätsmedizin Berlin. The company was formerly known as Nuvo Group Ltd. and changed its name to Holdco Nuvo Group D.G Ltd in May 2024. Holdco Nuvo Group D.G Ltd incorporated in 2006 and is headquartered in Tel Aviv, Israel. On August 22, 2024, Holdco Nuvo Group D.G Ltd filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Holdco Nuvo Group DG is in the Healthcare sector

Holdco Nuvo Group DG is in the Medical Devices industry

Holdco Nuvo Group DG is headquartered in Israel

https://www.nuvocares.com

No, Holdco Nuvo Group DG is not included in the S&P 500 index

No, Holdco Nuvo Group DG is not included in the NASDAQ 100 index

No, Holdco Nuvo Group DG is not included in the Dow Jones index

No data

The next expected earnings date for Holdco Nuvo Group DG is 29 November 2024